A fluorescent peptide that blocks the dimerization of a protein associated with the Epstein–Barr virus enables the imaging and growth inhibition of tumours attributed to the pathogen.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 /Â 30Â days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$99.00 per year
only $8.25 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Dayaram, T. & Marriott, S. J. J. Cell. Physiol. 216, 309–314 (2008).
Bollard, C. M. et al. J. Clin. Oncol. 32, 798–808 (2014).
Chan, A. T. et al. J. Clin. Oncol. 22, 1373–1381 (2004).
Ghosh, S. K., Perrine, S. P., Williams, R. M. & Faller, D. V. Blood 119, 1008–1017 (2012).
Fu, D. X. et al. Nat. Med. 14, 1118–1122 (2008).
Li, N., Thompson, S., Jiang, H., Lieberman, P. M. & Luo, C. Expert Opin. Drug Discov. 5, 1189–1203 (2010).
Jiang, L. et al. Nat. Biomed. Eng. 1, 0042 (2017).
Westhoff Smith, D. & Sugden, B. Viruses 5, 226–240 (2013).
Li, N. et al. PLoS ONE 5, e10126 (2010).
Sugden, B., Marsh, K. & Yates, J. Mol. Cell. Biol. 5, 410–413 (1985).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kosowicz, J., Lee, J. & Ambinder, R. Cancer: Seeing the ebb of a tumour virus. Nat Biomed Eng 1, 0059 (2017). https://doi.org/10.1038/s41551-017-0059
Published:
DOI: https://doi.org/10.1038/s41551-017-0059